These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Antiphospholipid syndrome and stroke]. Kitagawa Y. Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [Abstract] [Full Text] [Related]
23. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies. Proven A, Bartlett RP, Moder KG, Chang-Miller A, Cardel LK, Heit JA, Homburger HA, Petterson TM, Christianson TJ, Nichols WL. Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611 [Abstract] [Full Text] [Related]
24. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies. Obermoser G, Bitterlich W, Kunz F, Sepp NT. Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914 [Abstract] [Full Text] [Related]
25. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles. Kandiah DA, Krilis SA. Lupus; 1998 Oct; 7(5):323-32. PubMed ID: 9696136 [Abstract] [Full Text] [Related]
26. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1). Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN. Thromb Haemost; 1990 Nov 30; 64(3):478-84. PubMed ID: 2128977 [Abstract] [Full Text] [Related]
27. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Vivaldi P, Rossetti G, Galli M, Finazzi G. Haematologica; 1997 Nov 30; 82(3):345-7. PubMed ID: 9234588 [Abstract] [Full Text] [Related]
28. Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies. Le Querrec A, Arnout J, Arnoux D, Borg JY, Caron C, Darnige L, Delahousse B, Reber G, Sié P. Thromb Haemost; 2001 Aug 30; 86(2):584-9. PubMed ID: 11522007 [Abstract] [Full Text] [Related]
29. [The positive rate of lupus anticoagulant according to the each understanding disease in our hospital]. Omote M, Yoshida T, Asakura H, Ontachi Y, Hayashi T, Morishita E, Yamazaki M, Fujita S, Nakao S. Rinsho Byori; 2006 Sep 30; 54(9):903-9. PubMed ID: 17063871 [Abstract] [Full Text] [Related]
30. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J. Verh K Acad Geneeskd Belg; 2000 Sep 30; 62(5):353-72. PubMed ID: 11144685 [Abstract] [Full Text] [Related]
31. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome. Hanly JG, Smith SA. J Rheumatol; 2000 Sep 30; 27(9):2152-9. PubMed ID: 10990227 [Abstract] [Full Text] [Related]
32. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA. J Rheumatol; 2000 Dec 30; 27(12):2833-7. PubMed ID: 11128672 [Abstract] [Full Text] [Related]
33. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T. Thromb Haemost; 1997 Mar 30; 77(3):486-91. PubMed ID: 9065999 [Abstract] [Full Text] [Related]
34. Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activity. Pengo V, Brocco T, Biasiolo A, Rampazzo P, Carraro P, Zamarchi R. Blood; 1999 Dec 01; 94(11):3814-9. PubMed ID: 10572096 [Abstract] [Full Text] [Related]
35. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O. J Rheumatol; 2000 Jun 01; 27(6):1437-43. PubMed ID: 10852267 [Abstract] [Full Text] [Related]
36. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D, Boutière B, Sanmarco M. Ann Biol Clin (Paris); 2000 Jun 01; 58(5):557-74. PubMed ID: 11022099 [Abstract] [Full Text] [Related]
37. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I. Oosting JD, Derksen RH, Entjes HT, Bouma BN, de Groot PG. Thromb Haemost; 1992 May 04; 67(5):499-502. PubMed ID: 1519207 [Abstract] [Full Text] [Related]
38. Lupus anticoagulant testing with optical end point automation. Luddington R, Scales C, Baglin T. Thromb Res; 1999 Nov 01; 96(3):197-203. PubMed ID: 10588462 [Abstract] [Full Text] [Related]
39. [Laboratory diagnosis of lupus anticoagulant]. Swadźba J, Musiał J, Jankowski M, Bednarczyk M, Dyczek A, Szczeklik A. Pol Merkur Lekarski; 1996 Nov 01; 1(5):359-62. PubMed ID: 9273219 [Abstract] [Full Text] [Related]
40. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants. Lesperance B, David M, Rauch J, Infante-Rivard C, Rivard GE. Thromb Haemost; 1988 Oct 31; 60(2):217-9. PubMed ID: 3146139 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]